Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rosetta Genomics Ltd market cap is $36,200.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rosetta Genomics Ltd 52 week high is $1.68 as of May 01, 2024.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rosetta Genomics Ltd 52 week low is $0.0001 as of May 01, 2024.
Rosetta Genomics Ltd stock price today is $0.0061.
Rosetta Genomics Ltd stock price yesterday was $0.0122.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Rosetta Genomics Ltd’s P/E ratio is None.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Rosetta Genomics Ltd P/B ratio is 0.0330.
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Rosetta Genomics Ltd's EBITDA is N/A.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rosetta Genomics Ltd 50-day moving average is $0.0171.
Rosetta Genomics Ltd has N/A employees.